Compounds > indirubin-3'-monoxime
Page last updated: 2024-10-29

indirubin-3'-monoxime and Liver Neoplasms

indirubin-3'-monoxime has been researched along with Liver Neoplasms in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, T1
Kasai, M1
Kobayashi, S1

Other Studies

1 other study available for indirubin-3'-monoxime and Liver Neoplasms

ArticleYear
Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
    Experimental cell research, 2018, 09-15, Volume: 370, Issue:2

    Topics: Antineoplastic Agents; beta Karyopherins; Carcinoma, Hepatocellular; Cell Nucleus; Hep G2 Cells; Hum

2018